Jeng Brenda, DuBose Noah G, Martin Trevor B, Šilić Petra, Flores Victoria A, Zheng Peixuan, Motl Robert W
From the Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, Illinois.
Am J Phys Med Rehabil. 2024 Apr 1;103(4):284-292. doi: 10.1097/PHM.0000000000002312. Epub 2023 Oct 5.
This article provided an updated quantitative synthesis of physical activity levels in persons with multiple sclerosis compared with controls and other clinical populations.
A systematic search through PubMed, Scopus, and PsycINFO was conducted for articles published between August 2016 and July 2022. Articles that included a group comparison of at least one measurement of physical activity between adults with multiple sclerosis and controls or other clinical populations were included in the meta-analysis.
Twenty-four studies met the inclusion criteria and yielded a total of 119 comparisons. There was a moderate difference in physical activity levels between persons with multiple sclerosis and controls (effect size = -0.56, P < 0.01), but no significant difference between persons with multiple sclerosis and other clinical populations (effect size = 0.01, P = 0.90). The pooled effect sizes comparing multiple sclerosis with controls ( Q104 = 457.9, P < 0.01) as well as with clinical populations ( Q13 = 108.4, P < 0.01) were heterogeneous. Moderating variables included sex, disability status, measurement method, outcome, intensity, and application of a multiple sclerosis-specific cut-point.
Physical activity levels remain significantly lower in persons with multiple sclerosis compared with controls, but the magnitude of difference has become smaller over the past decade. There is a need for continued development of effective physical activity programs that can reach the greater community with multiple sclerosis.
本文提供了与对照组及其他临床人群相比,多发性硬化症患者身体活动水平的最新定量综合分析。
对2016年8月至2022年7月发表的文章在PubMed、Scopus和PsycINFO数据库中进行系统检索。纳入荟萃分析的文章需包含至少一项在成年多发性硬化症患者与对照组或其他临床人群之间进行身体活动测量的组间比较。
24项研究符合纳入标准,共产生119项比较。多发性硬化症患者与对照组之间的身体活动水平存在中度差异(效应量=-0.56,P<0.01),但多发性硬化症患者与其他临床人群之间无显著差异(效应量=0.01,P=0.90)。比较多发性硬化症患者与对照组(Q104=457.9,P<0.01)以及与临床人群(Q13=108.4,P<0.01)的合并效应量存在异质性。调节变量包括性别、残疾状况、测量方法、结果、强度以及多发性硬化症特定切点的应用。
与对照组相比,多发性硬化症患者的身体活动水平仍然显著较低,但在过去十年中差异程度已变小。需要持续开发有效的身体活动项目,以便让更多的多发性硬化症患者群体受益。